Cell Death Differ. 2017 Mar;24(3):469-480
Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination.
Jeon YK et al.



J Cell Biochem. 2018 Oct 26. doi: 10.1002/jcb.27586.
Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa‐miR‐2053 and lncRNA‐RP1‐86D1.3 axis expression in malignant pleural mesotheliom
Matboli M et al.



Mod Pathol. 2018 Oct 12. doi: 10.1038/s41379-018-0159-7.
Immunohistochemical evaluation of nuclear 5-hydroxymethylcytosine (5-hmC) accurately distinguishes malignant pleural mesothelioma from benign mesothelial proliferations.
Chapel DB et al.



Arch Pathol Lab Med. 2018 Jul 30. doi: 10.5858/arpa.2018-0273-OA.
Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas.
Berg KB et al.



O Oncotarget. 2018 9(32): 22785-801.
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.
Augeri S et al.



Radiol Oncol. 2018 Feb 7;52(2):160-166.
Matrix Metalloproteinases Polymorphisms as Baseline Risk Predictors in Malignant Pleural Mesothelioma
Strbac D et al.



Oncotarget. 2018 Apr 17;9(29):20781-20794
A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy.
Mönch D et al.



Lung Cancer. 2018 May;119:64-70.
Malignant cells from pleural fluids in malignant mesothelioma patients
reveal novel mutations
Sneddon S D et al.



Sci Rep. 2018 May 25;8(1):8135.
The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lung.
Gao F et al.



Oncol Lett. 2018 May;15(5):6825-6830
Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells.
Takehara Y et al.



Sci Rep. 2018 22;8(1):5059.
Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer.
Kiselev Y et al.



Front Oncol. 2018 Feb 23;8:40.
Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression.
Oehl K et al.



Am J Surg Pathol. 2018 Feb 12.
INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors.
Rooper LM et al.



Oncotarget. 2017 Dec 6;9(1):293-305.
Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma
Thompson JK et al.



Cancer Cytopathol. 2018 Jan 23.
Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
Doxtader EE et al.



Oncoimmunology. 2017 Sep 21;7(1):e1373235.
The "don't eat me" signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma.
Schürch CM et al.



Oncotarget. 2017 Aug 14;8(50):87234-87243
Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization.
Kim HR et al.



Front Immunol. 2017 Nov 20;8:1559.
Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth.
Agostinis C et al.



Hum Pathol. 2017 Aug 12.
Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.
Inaguma S et al.



Am J Surg Pathol. 2017 Oct 26.
Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.
Pillappa R et al.



Dis Markers. 2017;2017:1310478.
Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
Pulford E et al.



Oncotarget. 2017 Aug 7;8(41):70685-70694
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma.
Truini A et al.



Am J Surg Pathol. 2017 Dec;41(12):1675-1682.
PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma.
Chapel DB et al.



Oncol Rep. 2017 Oct;38(4):2148-2154.
Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1.
Yang L et al.



Histopathology. 2017 Mar;70(4):568-578.
The pathological features of idiopathic interstitial pneumonia-associated pulmonary adenocarcinomas.
Kojima Y. et al.



Mod Pathol. 2017 Sep 8
Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.
Vivero M et al.



Am J Surg Pathol. 2017 Nov;41(11):1561-1569.
INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity
Rooper LM et al.



Biosci Rep. 2017 Jul 19. pii: BSR20170852
The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis.
Li H. et al.



Sci Rep. 2017 Mar 31;7:45768
HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma.
Tsuji S et al.



Eur J Surg Oncol. 2017 May 18. pii: S0748-7983(17)30487-0.
Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study.
Valmary-Degano S et al.



Sci Rep. 2017 Jun 9;7(1):3140
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.
De Santi C et al.



American Journal of Surgical Pathology,
GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung.
Berg, Kyra B.; Churg, Andrew



Onco Targets Ther. 2017 Feb 24;10:1115-1122
miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8.
Li U et al



Lung Cancer. 2017 Jul;109:92-100
Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers
Duruisseaux M et al.



Oncotarget. 2017 Apr 18;8(16):26744-26754
Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma.
Inaguma S et al.